Julia P Gregory has been appointed to the board of directors of Freeline Therapeutics Ltd which is developing a gene therapy for haemophilia B. Ms Gregory is chair and chief executive of Isometry Advisors Inc, as well as a senior advisor to Morgan Stanley and M.M. Dillon & Co Inc. She also serves as a non-executive director to several other biopharmaceutical companies. Before entering industry, Ms Gregory worked as an investment banker at Dillon, Read & Co as well as at Punk, Ziegel & Co. She holds a degree in international affairs from George Washington University and an MBA from the Wharton School of the University of Pennsylvania, both in the US.
Freeline announced the appointment on 10 December 2019.
Copyright 2020 Evernow Publishing Ltd